Physician profile
Anne M Klassert
NPI 1467448985
$7,185.18
in general payments reported to CMS, 2019-2025
44 companies · $1,954 in 2025
The $1,954 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $726 · 2022: $1,384 · 2023: $1,804 · 2024: $1,318 · 2025: $1,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,067 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,066.81 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,125.73 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Urogen Pharma, INC. | $635.89 | 2022-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $523.92 | 2022-2025 | |
| Astellas Pharma US INC | $416.19 | 2021-2024 | Myrbetriq, Xtandi |
| Myriad Genetic Laboratories, INC. | $387.28 | 2021-2025 | Prolaris, Myrisk |
| Coloplast Corp | $350.72 | 2021-2025 | Speedicath |
| Blue Earth Diagnostics | $308.19 | 2021-2025 | Posluma |
| Abbvie INC. | $266.36 | 2022-2025 | |
| Amgen INC. | $246.98 | 2024-2025 | Repatha, Uplizna |
| Astrazeneca Pharmaceuticals Lp | $236.63 | 2023-2025 | Andexxa, Airsupra |
| Teleflex LLC | $212.51 | 2025 | Urolift |
| Janssen Pharmaceuticals, INC | $190.83 | 2022 | |
| 180 Medical, INC. | $174.97 | 2024 | Gentlecath |
| Genentech USA, INC. | $144.47 | 2022 | |
| Biogen, INC. | $142.15 | 2023 | Spinraza |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $125.89 | 2022 | |
| Organogenesis INC. | $124.99 | 2023 | Puraply Antimicrobial |
| Janssen Scientific Affairs, LLC | $124.94 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.47 | 2022 | |
| Ferring Pharmaceuticals INC. | $117.24 | 2024-2025 | Adstiladrin |
| Inspire Medical Systems, INC. | $117.19 | 2023 | Inspire |
| Sumitomo Pharma America, INC. | $100.25 | 2023-2025 | Gemtesa |
| Advanced Oxygen Therapy INC. | $87.32 | 2023 | Topical Oxygen Chamber For Extremities |
| Tolmar, INC. | $81.87 | 2023-2025 | Eligard |
| Telix Pharmaceuticals | $81.45 | 2024-2025 | Illuccix |
| Neurelis, INC. | $81.03 | 2024 | Valtoco |
| Hollister Incorporated | $75.20 | 2022-2023 | Infyna Chic, Vapro Plus Pocket, Vapro |
| Laborie Medical Technologies Corp. | $70.43 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Dentsply Ih Ab | $68.61 | 2023-2025 | Lofric, Lofric |
| Endo Pharmaceuticals INC. | $63.12 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $58.36 | 2021 | |
| Alnylam Pharmaceuticals INC. | $49.07 | 2021-2023 | Oxlumo |
| Pfizer INC. | $48.07 | 2021-2024 | |
| Myovant Sciences INC. | $35.83 | 2021-2022 | |
| Photocure INC | $27.07 | 2024 | Cysview |
| Urovant Sciences INC | $21.17 | 2022 | |
| Immunitybio, INC. | $20.98 | 2025 | |
| Clarus Therapeutics INC. | $20.79 | 2021 | |
| Progenics Pharmaceuticals, INC. | $19.58 | 2025 | |
| Provepharm INC. | $18.03 | 2025 | Bludigo |
| Dentsply Ih INC. | $17.09 | 2021 | |
| Endo USA, INC. | $16.68 | 2025 | Aveed, Xiaflex |
| Civco Medical Instruments | $13.88 | 2024 | |
| Olympus America INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Klassert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.